The Cancer Letter

Inside information on cancer research and drug development

Biden requests $6.5B to fund cancer-focused ARPA-H, an advanced research agency to be housed within NIH

In Briefs

Deborah Schrag named chair of the Department of Medicine at Memorial Sloan Kettering
Carolyn Starrett named CEO of Flatiron Health
Brian Bolwell named chair of physician leadership and development at Cleveland Clinic
California legislature passes Cancer Patients Bill of Rights
Elizabeth Herbert named VP for Network Services at Smilow Cancer Hospital
Harvard Medical School receives $9M for rare cancer research

Drugs & Targets

Sacituzumab govitecan receives FDA approval for TNBC
FDA approves new dosing regimen for cetuximab
NCCN recognizes Oncotype DX test as the only multigene test to predict chemotherapy benefit in node-positive early-stage breast cancer
TriSalus Life Sciences, MD Anderson collaboration to evaluate treatment of solid tumors
Abecma receives FDA approval for multiple myeloma
Sarclisa in combination with carfilzomib, dexamethasone receives FDA approval for relapsed or refractory multiple myeloma

In The Clinic

FreeTrials & Tribulations

City of Hope leads Cancer Patients Bill of Rights resolution, aimed at expanding access to unleash the full benefits of cancer care innovation

City of Hope leads Cancer Patients Bill of Rights resolution, aimed at expanding access to unleash the full benefits of cancer care innovation
The Delaware experience:
FreeTrials & Tribulations
Tackling racial disparities through novel approaches to engage communities in research Keeping in contact with those at risk is key to colorectal and breast cancer screening during COVID-19
FreeTrials & Tribulations
An oncologist's perspective on measuring success in the clinic
Trials & Tribulations
How AI uncovers “invisible” socioeconomic risk factors to improve cancer care
FreeTrials & Tribulations

Latest Issue

UPCOMING EVENTS

No post found

The Cancer Letter is an independent weekly news publication and the leading source for information on the issues that shape oncology.